Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Bristol-Myers Squibb Co (NYSE:BMY)

55.23
Delayed Data
As of Dec 08
 -0.01 / -0.02%
Today’s Change
49.03
Today|||52-Week Range
77.12
-19.71%
Year-to-Date
Why AstraZeneca plc Stock Slumped in November
Dec 07 / MotleyFool.com - Paid Partner Content
AVEO Partner Submits Response to Questions on Tivozanib
Nov 29 / Zacks.com - Paid Partner Content
Bristol-Myers Reports Data from Opdivo Combination Studies
Dec 06 / Zacks.com - Paid Partner Content
The Zacks Analyst Blog Highlights: Bristol-Myers, Google, Deere, Halliburton and Amer...
Nov 29 / Zacks.com - Paid Partner Content
3 Beaten-Up Healthcare Stocks: Are They Bargains?
Dec 06 / MotleyFool.com - Paid Partner Content
Big Pharma healthcare R&D steps out into the open
Nov 29 / FT.com - Paid Partner Content
Why Exelixis Was a Top Stock in 2016 So Far
Dec 02 / MotleyFool.com - Paid Partner Content
Top Research Reports for Alphabet, Deere & Bristol-Myers
Nov 28 / Zacks.com - Paid Partner Content
Pharma Stock Roundup: Nivalis Falls on Study Data, Priority Reviews for Merck's Keytr...
Dec 02 / Zacks.com - Paid Partner Content
3 Top Drug Stocks for Your Retirement Portfolio
Nov 28 / MotleyFool.com - Paid Partner Content
Heat Biologics Stock Falls on Negative Bladder Cancer Data
Dec 01 / Zacks.com - Paid Partner Content
Pharma Stock Roundup: Lilly Alzheimer's Drug Fails, J&J in Acquisition Talks with ALI...
Nov 28 / Zacks.com - Paid Partner Content
3 Ways Organovo Holdings, Inc. Plans to Grow Exponentially for Years to Come
Dec 01 / MotleyFool.com - Paid Partner Content
AstraZeneca given green light to resume cancer drug trials
Nov 22 / FT.com - Paid Partner Content
ARIAD's Leukemia Drug Iclusig Gets Full Approval in U.S.
Nov 30 / Zacks.com - Paid Partner Content
Big pharma is failing to do enough for poor countries
Nov 13 / FT.com - Paid Partner Content